179 related articles for article (PubMed ID: 3039178)
1. A mouse model for poliovirus neurovirulence identifies mutations that attenuate the virus for humans.
La Monica N; Almond JW; Racaniello VR
J Virol; 1987 Sep; 61(9):2917-20. PubMed ID: 3039178
[TBL] [Abstract][Full Text] [Related]
2. Identification of two determinants that attenuate vaccine-related type 2 poliovirus.
Ren RB; Moss EG; Racaniello VR
J Virol; 1991 Mar; 65(3):1377-82. PubMed ID: 1847458
[TBL] [Abstract][Full Text] [Related]
3. Translation deficiency of the Sabin type 3 poliovirus genome: association with an attenuating mutation C472----U.
Svitkin YV; Cammack N; Minor PD; Almond JW
Virology; 1990 Mar; 175(1):103-9. PubMed ID: 2155504
[TBL] [Abstract][Full Text] [Related]
4. Mutations in Sabin 2 strain of poliovirus and stability of attenuation phenotype.
Rezapkin GV; Fan L; Asher DM; Fibi MR; Dragunsky EM; Chumakov KM
Virology; 1999 May; 258(1):152-60. PubMed ID: 10329577
[TBL] [Abstract][Full Text] [Related]
5. Mouse neurovirulence determinants of poliovirus type 1 strain LS-a map to the coding regions of capsid protein VP1 and proteinase 2Apro.
Lu HH; Yang CF; Murdin AD; Klein MH; Harber JJ; Kew OM; Wimmer E
J Virol; 1994 Nov; 68(11):7507-15. PubMed ID: 7933134
[TBL] [Abstract][Full Text] [Related]
6. Construction and properties of intertypic poliovirus recombinants: first approximation mapping of the major determinants of neurovirulence.
Agol VI; Grachev VP; Drozdov SG; Kolesnikova MS; Kozlov VG; Ralph NM; Romanova LI; Tolskaya EA; Tyufanov AV; Viktorova EG
Virology; 1984 Jul; 136(1):41-55. PubMed ID: 6330995
[TBL] [Abstract][Full Text] [Related]
7. Reduced mouse neurovirulence of poliovirus type 2 Lansing antigenic variants selected with monoclonal antibodies.
La Monica N; Kupsky WJ; Racaniello VR
Virology; 1987 Dec; 161(2):429-37. PubMed ID: 2825415
[TBL] [Abstract][Full Text] [Related]
8. Molecular genetic analysis of revertants from a poliovirus mutant that is specifically adapted to the mouse spinal cord.
Jia Q; Hogle JM; Hashikawa T; Nomoto A
J Virol; 2001 Dec; 75(23):11766-72. PubMed ID: 11689657
[TBL] [Abstract][Full Text] [Related]
9. Mapping of mutations associated with neurovirulence in monkeys infected with Sabin 1 poliovirus revertants selected at high temperature.
Christodoulou C; Colbere-Garapin F; Macadam A; Taffs LF; Marsden S; Minor P; Horaud F
J Virol; 1990 Oct; 64(10):4922-9. PubMed ID: 2168976
[TBL] [Abstract][Full Text] [Related]
10. [Genetic determinants of neurovirulence and attenuation of poliovirus].
Azol VI
Mol Gen Mikrobiol Virusol; 1988 Jan; (1):3-9. PubMed ID: 2833691
[TBL] [Abstract][Full Text] [Related]
11. Transgenic mice carrying the human poliovirus receptor: new animal models for study of poliovirus neurovirulence.
Horie H; Koike S; Kurata T; Sato-Yoshida Y; Ise I; Ota Y; Abe S; Hioki K; Kato H; Taya C
J Virol; 1994 Feb; 68(2):681-8. PubMed ID: 8289371
[TBL] [Abstract][Full Text] [Related]
12. Mapping of attenuating sequences of an avirulent poliovirus type 2 strain.
Moss EG; O'Neill RE; Racaniello VR
J Virol; 1989 May; 63(5):1884-90. PubMed ID: 2539491
[TBL] [Abstract][Full Text] [Related]
13. Influenza virus: appearance of high mouse-neurovirulent recombinants.
Vallbracht A; Flehmig B; Gerth HJ
Intervirology; 1979; 11(1):16-22. PubMed ID: 429139
[TBL] [Abstract][Full Text] [Related]
14. Genetic basis of the neurovirulence of type 1 polioviruses isolated from vaccine-associated paralytic patients.
Li J; Zhang LB; Yoneyama T; Yoshida H; Shimizu H; Yoshii K; Hara M; Nomura T; Yoshikura H; Miyamura T; Hagiwara A
Arch Virol; 1996; 141(6):1047-54. PubMed ID: 8712922
[TBL] [Abstract][Full Text] [Related]
15. Nucleotide sequence of a neurovirulent variant of the type 2 oral poliovirus vaccine.
Pollard SR; Dunn G; Cammack N; Minor PD; Almond JW
J Virol; 1989 Nov; 63(11):4949-51. PubMed ID: 2552175
[TBL] [Abstract][Full Text] [Related]
16. Studies on neurovirulence in poliovirus-sensitive transgenic mice and cynomolgus monkeys for the different temperature-sensitive viruses derived from the Sabin type 3 virus.
Abe S; Ota Y; Doi Y; Nomoto A; Nomura T; Chumakov KM; Hashizume S
Virology; 1995 Jun; 210(1):160-6. PubMed ID: 7793068
[TBL] [Abstract][Full Text] [Related]
17. Neurovirulence of the intertypic poliovirus recombinant v3/a1-25: characterization of strains isolated from the spinal cord of diseased monkeys and evaluation of the contribution of the 3' half of the genome.
Agol VI; Drozdov SG; Frolova MP; Grachev VP; Kolesnikova MS; Kozlov VG; Ralph NM; Romanova LI; Tolskaya EA; Viktorova EG
J Gen Virol; 1985 Feb; 66 ( Pt 2)():309-16. PubMed ID: 2981970
[TBL] [Abstract][Full Text] [Related]
18. Mutation of a single conserved nucleotide between the cloverleaf and internal ribosome entry site attenuates poliovirus neurovirulence.
De Jesus N; Franco D; Paul A; Wimmer E; Cello J
J Virol; 2005 Nov; 79(22):14235-43. PubMed ID: 16254358
[TBL] [Abstract][Full Text] [Related]
19. RNA sequence variants in live poliovirus vaccine and their relation to neurovirulence.
Chumakov KM; Norwood LP; Parker ML; Dragunsky EM; Ran YX; Levenbook IS
J Virol; 1992 Feb; 66(2):966-70. PubMed ID: 1309923
[TBL] [Abstract][Full Text] [Related]
20. Evolution of the Sabin type 1 poliovirus in humans: characterization of strains isolated from patients with vaccine-associated paralytic poliomyelitis.
Georgescu MM; Balanant J; Macadam A; Otelea D; Combiescu M; Combiescu AA; Crainic R; Delpeyroux F
J Virol; 1997 Oct; 71(10):7758-68. PubMed ID: 9311861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
